
Potential Targeted Therapy for Pediatric Brain Cancer Identified by Dana-Farber Team
Newswise — Boston – An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric and young patients with a form of high …